Human K(ATP) channelopathies: diseases of metabolic homeostasis. - Wikidata - wikimedia - TriplyDB

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

http://www.wikidata.org/entity/Q33906965

about

ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force Potassium Channels and Human Epileptic Phenotypes: An Updated Overview Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers Ion Channels in the Heart ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS/calmodulin/CaMKII signaling cascade.Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.Replication of obesity and diabetes-related SNP associations in individuals from Yucatán, México.K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.Genome-wide analysis of DNA methylation before-and after exercise in the thoroughbred horse with MeDIP-Seq.Antiobesity strategy targets energy economy safeguards.Measuring and evaluating the role of ATP-sensitive K+ channels in cardiac muscle.Replacing SNAP-25b with SNAP-25a expression results in metabolic disease.Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of aging Cardiac specific ATP-sensitive K+ channel (KATP) overexpression results in embryonic lethality ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.KATP Channels in the Cardiovascular System.Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.Role of Kir6.2 subunits of ATP-sensitive potassium channels in endotoxemia-induced cardiac dysfunction.Plasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning.Minor differences in the molecular machinery mediating regulated membrane fusion has major impact on metabolic health.Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy.Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.Natriuretic peptides modulate ATP-sensitive K(+) channels in rat ventricular cardiomyocytes.Activation of ATP-sensitive potassium channels facilitates the function of human endothelial colony-forming cells via Ca2+ /Akt/eNOS pathway.Ion channelopathies in endocrinology: recent genetic findings and pathophysiological insights.The molecular genetics of sulfonylurea receptors in the pathogenesis and treatment of insulin secretory disorders and type 2 diabetes.Redox control of cardiac excitability.Inward-rectifying potassium channelopathies: new insights into disorders of sodium and potassium homeostasis.ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.Biology of stress revisited: intracellular mechanisms and the conceptualization of stress.The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.SNAP-25b-deficiency increases insulin secretion and changes spatiotemporal profile of Ca2+oscillations in β cell networks.Differential roles for SUR subunits in KATP channel membrane targeting and regulation.Diazoxide preconditioning antagonizes cytotoxicity induced by epileptic seizures.K(ATP) channels process nucleotide signals in muscle thermogenic response.Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide.

P2860

Q26744723-08749280-E76E-4C35-8008-9565F304CB03 Q26750434-804D1A16-8175-472D-A179-CEDBB999A08C Q26775424-7BEB578D-B27F-48AD-9EA1-C66797CD7451 Q26829681-04E53E4A-74F2-49A5-91EB-3D2562FC809B Q33778841-F5AD890C-C9B4-4E30-98E0-F92BD6668556 Q33867615-B41ABBDA-CCF7-4EC0-99BE-725BEE451C20 Q33898386-411C3B5E-D0EF-4F3B-AD64-004B9F7FEBE7 Q34531657-FBCAAC95-9372-4A6E-A498-E41E09BB06A2 Q34808521-C987D3C9-5AE4-454E-BF71-9C8B140521CC Q35087287-CE5B4193-5A3B-4659-B57B-F04BE5CFECD4 Q35171519-055F826A-EEA5-452A-B90D-265C5A38A2C2 Q35188492-517C7204-8496-4B63-8EBB-71BEF1C8A3DF Q35399304-D2774F53-0A8A-4D98-BCF8-97D6C896BCB3 Q35803289-788439F7-9714-490E-B8C9-4063BA9C87EE Q35946184-FB196C7A-E0AD-4174-8D27-08563FFD8779 Q36121718-12E597A1-7EF3-4606-A92D-E4BD99362A8C Q36176733-C967DF0A-26AC-4C72-A044-DB48BEE25E63 Q36322637-06095EB0-6D4B-4598-8059-F1D0802C893C Q36422478-21E4D8AB-877C-4E61-90D6-83321E5422C7 Q36490560-466725E3-C564-4BE1-B848-D0FADFC374B1 Q36846892-2B51375C-E657-4707-9EFB-8989D28AFE6B Q37071917-E8B15A06-5635-4833-AB97-B0BD139BD19F Q37237983-5E4F6E8C-3AC0-4B6E-A866-3FAD2A7A46E4 Q37457567-675D27EF-EA0F-40CD-B8A0-E761BF0AFD62 Q37496226-D672F339-5A40-4CAB-8755-207109B0C2F7 Q37633999-8FFB1145-1BE1-4DD3-89BF-24CACD648647 Q37662882-9DE980B4-71D8-4AEF-8B2E-6F5A47A02808 Q37845693-EAB35FCD-E79C-4CD1-9B37-106D5C2E048F Q37942030-DB9B9D3A-293D-4D0F-A0DF-FC57AC7FFFDE Q38035054-CF5382AF-A74C-4668-8934-C0DBBAF7A5C8 Q38217762-C0ADE86A-6CB4-43A9-84AC-94A6CD5335D4 Q38821425-F6BB50E6-AF75-4863-846B-F7A2E2299F6C Q39302961-37555CCD-886D-407A-A090-251C5E365798 Q39783056-A57152EC-DAB9-46BC-B932-60821552BCE0 Q41353485-C100B2C5-4E41-4A65-A226-FB2455AA8EB9 Q42575260-BB4F0F20-F19C-4A2A-BD2D-FC8C67DECA89 Q42844464-66E45D3C-C508-447D-BD26-058278DC8BCB Q42868512-0E0F57DF-63C0-479A-8058-B80EE0F1762E Q44052261-5F60EFFE-B588-416E-93EC-BB0CB839878E Q44513500-5D12D450-F53D-4B31-B1C9-6225450FB6F9

P2860

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

http://www.wikidata.org/entity/Q33906965

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@ast

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@en

type

label

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@ast

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@en

prefLabel

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@ast

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@en

P1433

Q33906965-CE640DB9-B2EC-4BE2-8DAE-0823DDEA4625

P1476

Q33906965-0DD32874-1A29-4FB0-AA26-31372A9C79C2

P2093

Q33906965-126F511A-4760-4A7D-9915-295C025B5A89

Q33906965-DA836E2A-452E-477F-BD72-3B157DD8F80D

P2860

Q33906965-00C7CB7D-C094-4D12-832E-9A894E97EF74

Q33906965-01FCE331-3005-4E0F-A96F-ED313C292C09

Q33906965-0315E1FC-0390-49F6-B2F0-E811DA4A2FE1

Q33906965-0704EDF9-91A6-46AC-913E-8274F6A0727E

Q33906965-07786AA9-AFA9-4952-B98A-C489AF6D122A

Q33906965-07C5A6A0-879E-423A-81E9-C432CCE78BEC

Q33906965-0A672420-55AF-4296-A895-E59AF369F90D

Q33906965-0BECAB90-090A-43C8-8D3B-F5DBE784FF57

Q33906965-0C819668-1790-4792-B7CE-49856AA4E886

Q33906965-0DB64C9A-D2A1-4C49-BB04-3BDD26851836

P2888

Q33906965-B13E8B02-21C8-4D05-AF02-F25C5A19C9F5

P304

Q33906965-939603FF-BAE2-458D-9BA5-FED9F51E041B

P31

Q33906965-1FE6AF9F-24F4-4DF9-BD1F-B6F1C90B2F7F

Q33906965-C0FEEB39-26B3-4583-ACAA-7FF7821D63B0

P356

Q33906965-3185BABB-D707-464A-A796-9323AEBA0C68

P433

Q33906965-EDF722EF-19F5-44D7-BAC7-711E9C5063FC

P478

Q33906965-1FD1FAA5-F8FC-4839-83D5-C4D0FCBD0FDF

P577

Q33906965-7D4400D1-EB4B-42A2-B085-782E7CED3084

Q33906965-7F4D17DD-1560-4F6D-AA94-FE81145AC673

P5875

Q33906965-20D6D69C-7E77-43E9-ACF5-6D6D7C3F5A94

P6179

Q33906965-870CB045-A9FE-492A-AF08-5CF45FBEC7AB

P698

Q33906965-3B927E78-6A6B-4183-BE99-D28E07296F2C

P921

Q33906965-2B653232-E608-44DD-8898-B069DF900832

Q33906965-42AA4D70-8A78-427E-9E38-E48146D26CB2

Q33906965-4CD1A5CC-7E27-4B6B-B998-E826E5B9F681

Q33906965-87BBA524-EFA0-4744-BB65-8AEF8B41A7CB

Q33906965-BFF2CE24-CE2C-460D-8E1C-336E3A0E7F50

P932

Q33906965-B49562D9-8F91-44BC-B50C-BB500507AE73

P356

S00424-009-0771-Y

P1433

Pfluegers Archiv

P1476

Human K(ATP) channelopathies: diseases of metabolic homeostasis.

@en

P2093

Andre Terzic

http://www.w3.org/2001/XMLSchema#string

Timothy M Olson

http://www.w3.org/2001/XMLSchema#string

P2860

Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor

Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes

KCNQ1 gain-of-function mutation in familial atrial fibrillation

The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide

Nuclear KATP channels trigger nuclear Ca(2+) transients that modulate nuclear function.

Kir6.2 is required for adaptation to stress.

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels

ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating

P2888

s00424-009-0771-y

P304

295-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00424-009-0771-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

460

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40769135

http://www.w3.org/2001/XMLSchema#string

P6179

1004412638

http://www.w3.org/2001/XMLSchema#string

P698

20033705

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

transport protein

membrane proteins

P932

2883927

http://www.w3.org/2001/XMLSchema#string